Drug Approval | January 14, 2022
WHO recommends two new drugs for COVID-19
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
It recommends using the vaccine to prevent the spread of the disease
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
Subscribe To Our Newsletter & Stay Updated
